Friday, October 23, 2020
IT / EN
August 1, 2020 | Publications, Working papers | By MG

Biomed Europa:after the coronavirus,a public infrastructure to overcomethe pharmaceutical oligopoly

Working paper CIRIEC

“As of June 30th, 2020, the global outbreak of Severe Acute Respiratory Syndrome(SARS)—associated coronavirus 2 (SARS-CoV-2)has claimed about 500,000lives, with over 10 million confirmed cases and nearly 3 billion people around the world under some form of lockdown. The COVID-19 pandemic has exposed profound weaknesses in a global health system that in the last decades relied in most countries too heavily on the pro-profit private sector for the discovery, development and distribution of new drugs.” […]

 

Click here to read the working paper

Arrow to go back to the top of the page.